Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nmni.2020.100710 http://scihub22266oqcxt.onion/10.1016/j.nmni.2020.100710 33088575!7558214!33088575     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33088575&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       New+Microbes+New+Infect 2020 ; 38 (?): 100710 Nephropedia Template TP {{tp|p=33088575|t=2020. Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |pdf=|usr=}}{{33088575}} gab.com Text Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences JO: New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=33088575 #FOAvip Funding and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the coronavirus disease 2019 epidemic, several treatments are available to treat patients infected with the virus. Some are protected by patents, such as remdesivir, others0020stare not, such as hydroxychloroquine. We wanted to observe the possible correlation between the fact, for an academic doctor in infectious diseases, of having benefited from funding by Gilead Sciences, producer of remdesivir, and the public positions taken by this doctor towards hydroxychloroquine. Our results show a correlation (Spearman test, p = 0.017) between the amount received from the Gilead Sciences company and public opposition to the use of hydroxychloroquine in France. This should open up the debate on the role of the interest links of doctors with pharmaceutical companies in the medical and scientific public debate. Twit Text FOAVip Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences ????New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=33088575 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33088575 #FOAvip English Wikipedia <ref>{{Cite pmid|33088575}}</ref> Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences #MMPMID33088575 Roussel Y; Raoult D New Microbes New Infect 2020[Nov]; 38 (?): 100710 PMID33088575show ga Funding and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the coronavirus disease 2019 epidemic, several treatments are available to treat patients infected with the virus. Some are protected by patents, such as remdesivir, others0020stare not, such as hydroxychloroquine. We wanted to observe the possible correlation between the fact, for an academic doctor in infectious diseases, of having benefited from funding by Gilead Sciences, producer of remdesivir, and the public positions taken by this doctor towards hydroxychloroquine. Our results show a correlation (Spearman test, p = 0.017) between the amount received from the Gilead Sciences company and public opposition to the use of hydroxychloroquine in France. This should open up the debate on the role of the interest links of doctors with pharmaceutical companies in the medical and scientific public debate. ?Influence of conflicts of interest on public positions in the COVID-19(epmc).pdf DeepDyve Pubget Overpricing